Ba'ax u k'áat u ya'al "Clear"?
Le ba'alche'o' ma' u bisik le mutación. ma' ken u yantal le k'oja'anilo' yéetel ma' ken u máansaj.
Peek Centronuclear Myopathy In Border Collie (CNM-BC)
Centronuclear Myopathy (CNM) is a genetic disorder affecting Border Collies, characterized by muscle weakness and exercise intolerance. A DNA test for CNM is essential for responsible breeding, helping to identify carriers and reduce the risk of this debilitating condition. This simple yet effective test enables dog owners and breeders to make informed decisions, ensuring healthier puppies. By understanding the genetic predisposition to CNM, owners can provide better care and management for affected dogs. Regular screening through DNA testing not only promotes the health of individual dogs but also contributes to the overall well-being of the Border Collie breed. Invest in a CNM DNA test today to safeguard your canine companion’s future.
Abreviatura: CNM-BC
Mutación analizada: DNM2 c.1393C>T
Ereensia : Autosómico recesivo
Acrónimo
CNM-BC
Frecuencia observada
Severidad clínica
Clasificación clínica
K'oja'anilo'ob musculares
Mutación analizada
DNM2 c.1393C>T
p.(R465W)
p.(R465W)
Bix u herencia
Autosómico recesivo
Resumen le prueba:
Centronuclear Myopathy (CNM) is a genetic disorder affecting Border Collies, characterized by muscle weakness and exercise intolerance. A DNA test can identify carriers and affected dogs, enabling breeders to make informed decisions to reduce the prevalence of this condition. Early detection through genetic testing can help owners manage symptoms and improve the quality of life for affected pets. Responsible breeding practices based on test results play a crucial role in preserving the health of the breed. Overall, DNA testing for CNM enhances breed welfare and promotes healthier generations of Border Collies.
Yaan ti' le paquete: Basic
Le prueba ADN táan incluida ku káajal le ti' k paquete Basic — yéetel xan táakpaja'an ti' le paquetes Basic, Standard, Advanced, Complete.
Ilawil le paquetes u prueba ADN →yéey le paquete ku bin utsil ti' u estrategia u crianza wa toj óolal u ba'alche'ob.
Overview of Centronuclear Myopathy (CNM) in Border Collies
Centronuclear Myopathy (CNM) is a hereditary muscle disorder found in Border Collies. Characterized by weakness and muscle atrophy, this genetic condition significantly affects the dog's motor capabilities and overall quality of life. CNM results from mutations in specific genes leading to improper muscle fiber development and function.
Signos yéetel síntomas clínicos
Dogs affected by CNM typically exhibit clinical signs from a young age. Common symptoms include muscle weakness, reduced physical activity, exercise intolerance, abnormal gait, and muscle wasting. Severely affected dogs may have difficulty standing or walking, potentially impacting their ability to perform routine daily activities.
Genetic Basis of Centronuclear Myopathy
CNM in Border Collies is inherited in an autosomal recessive manner. This means a dog must inherit two copies of the mutated gene—one from each parent—to exhibit symptoms. Dogs carrying only one copy of the mutation (carriers) do not typically show signs but can pass the mutation onto offspring.
Importance of DNA Testing for CNM
DNA testing is essential for identifying the CNM mutation in Border Collies. Early identification of affected and carrier dogs helps breeders make informed decisions, preventing the spread of the condition. DNA testing enables responsible breeding practices, assisting in reducing and eventually eliminating the occurrence of this debilitating condition.
Interpretation of DNA Test Results
The DNA test clearly distinguishes three genetic statuses:
Recommendations for Breeders and Owners
Breeders are advised to conduct CNM DNA testing in breeding dogs before mating. Clear mating strategies should be selected to avoid producing affected puppies. Owners of Border Collies should consult veterinarians and genetic specialists for guidance on managing dogs diagnosed with CNM, ensuring the best possible quality of life.
Ch'i'ibalil k'ajóolta'an uti'al le pruebao': Centronuclear Myopathy In Border Collie (CNM-BC)
- Bearded Collie
- Border Collie
- Farm Collie
- Old Farm Collie
- Rough Collie
- Scottish Collie
- Scottish Rough Collie
- Scottish Smooth Collie
- Smooth Collie
🧬 Interpretation of genotypes CNM-BC
Genotipo
Estaado
🟡 N/N
Ma' portador - Mina'an riesgo
🟡 N/CNM-BC
Portador - Mina'an riesgo
❌ CNM-BC/CNM-BC
Afectado - Ti' riesgo
FAQ: u na'atik u tsoolil
¿Serio wa jump'éel "portador"?
Ma'. Le ba'alche'o' tu general toj ba'ale' je'el u páajtal u transmitir le mutación ti' u ch'i'ibal.
¿Kux túun wa juntúul ba'alche' "Afectado"?
ku bisik ka'ap'éel copias mutadas. Le signos clínicos ku pa'ta'al dependiendo de le k'oja'anilo'. ma' unaj u ch'íijil.
Ba'axten yaan jela'anil ichil xiib yéetel ko'olel?
Yaan k'oja'anilo'ob yaan ba'al u yil yéetel u núup, le beetike' u ye'esajilo'obe' ku jelpajal je'el bix le u sexo ba'alche'.
Predecir u ch'i'ibal
N/N (ma-portador)
N/CNM-BC (Portador)
CNM-BC/CNM-BC (Afectado)
Prueba de ADN FAQ
Ba'ax ku yilik le prueba ADNa'?
This DNA test detects the mutation associated with Centronuclear Myopathy In Border Collie (CNM) in order to identify clear, carrier, or at-risk animals.
Ba'axten u probar jump'éel ba'alche' ku ch'íijil?
Le prueba ADN ku yáantik le criadores planificar acoplamientos asab seguros yéetel xu'ulsiko'ob le riesgo u transmitir le mutación ti' le descendencia.
¿Ba'ax u modoil u herencia le pruebaa'?
Le modo herencia reportado utia'al u prueba jach Autosómico Recesivo.
Ba'ax mutación ku xak'alta'al te' pruebaa'?
This test analyses the mutation DNM2 c.1393C>T.
¿K'a'abéet wa u k'astal jump'éel ba'alche' ku bisik?
ma' jach k'a'abéet. U tsoolil yaantal yo'osal u patrón le herencia yéetel le genotipo resultante.
Referencias
Böhm Johann, Barthélémy Inès, Landwerlin Charlène, BlanchardGutton Nicolas, Relaix Frédéric, Blot Stéphane, Laporte Jocelyn, Tiret Laurent. A dog model for centronuclear myopathy carrying the most common DNM2 mutation. Dis Model Mech. 2022 Apr 1;15(4):dmm049219. doi: 10.1242/dmm.049219. Epub 2022 Apr 14.